Fig. 2From: The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosisImaging abnormalities at first and second MDT and corresponding final CS diagnosis in all patients (A), only patients with baseline immunosuppressive treatment (B), only patients without baseline immunosuppressive treatment (C) and only patients without baseline or newly started immunosuppressive treatment (D)Back to article page